fbpx

J&J Announces ACUVUE OASYS with Transitions Light Intelligent Technology

Johnson & Johnson Vision announced on April 11 ACUVUE OASYS® with Transitions® Light Intelligent Technology™ first of its kind contact lens that provides wearers with vision correction and a dynamic photochromic filter that helps to continuously balance the amount of light entering the eye. These contact lenses quickly and seamlessly adjust from clear to dark in response to changing light conditions; reducing exposure to bright light indoors and outdoors, including filtering blue light and blocking UV rays.

“This innovation was born out of deep research into consumer lifestyle needs and fits our future-forward approach to caring for human sight,” said Dr. Xiao-Yu Song, Global Head of R&D for Johnson & Johnson Vision. “ACUVUE OASYS® with Transitions® creates and defines an entirely new category of contact lenses that will address unmet needs for patients. After more than a decade of product development and numerous clinical trials involving more than 1,000 patients, we are excited to bring to market a solution to help contact lenses wearers manage the changing light conditions they face every day in their modern, active lives.”

This strategic partnership between Johnson & Johnson Vision (JJV) and Transitions Optical combines the respective strengths of each company. While ACUVUE® is the world leader in contact lenses, Transitions Optical is the leading provider of photochromic (smart adaptive) lenses world wide. The two companies are working together to research and deliver best-in-class vision care innovations.

ACUVUE OASYS® with Transitions® has received 510(k) clearance from the U.S. Food and Drug Administration and is indicated for the attenuation of bright light. The two-week reusable, spherical contact lens will be marketed by Johnson & Johnson Vision Care, Inc. and will be commercially available in first half of 2019.

Featured Posts

Essilor Stellest Lenses Now Available in Sun Tints and an Extended Range

Essilor® Stellest™ lenses slow down myopia progression by 67% on average, compared to single vision lenses, when worn 12 hours a day.

Learn More

WCO and CooperVision Partner on Myopia Management Navigator Educational Resource

Interactive Guide Aimed at Boosting Adoption of Myopia Management Global Standard of Care

Read more
contact lens institute

New Research Report Highlights Actions to Attract Potential & Former Contact Lens Patients

Contact Lens Institute™ Data Illustrates Significant Upside Opportunity for Eye Care Practices and Pinpoints What Drives Consideration

Read more

EssilorLuxottica to Release New Research Findings at ARVO, Including Five-year Clinical Findings of Essilor Stellest Lenses

EssilorLuxottica is taking part in the 2024 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Seattle, USA, where it will present new findings from its studies on advancements in myopia management with Essilor Stellest lenses..

Read more
ZEISS Canada

ZEISS, Pioneering Excellence in Optical Innovation and Service

ZEISS, the global leader in optical science, is investing in innovation and making further advancements in the industry’s best service and quality.

Read more

Essilor Stellest Lenses Now Available in Sun Tints and an Extended Range

Essilor® Stellest™ lenses slow down myopia progression by 67% on average, compared to single vision lenses, when worn 12 hours a day.

Learn More

WCO and CooperVision Partner on Myopia Management Navigator Educational Resource

Interactive Guide Aimed at Boosting Adoption of Myopia Management Global Standard of Care

Read More
contact lens institute

New Research Report Highlights Actions to Attract Potential & Former Contact Lens Patients

Contact Lens Institute™ Data Illustrates Significant Upside Opportunity for Eye Care Practices and Pinpoints What Drives Consideration

Read More

EssilorLuxottica to Release New Research Findings at ARVO, Including Five-year Clinical Findings of Essilor Stellest Lenses

EssilorLuxottica is taking part in the 2024 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Seattle, USA, where it will present new findings from its studies on advancements in myopia management with Essilor Stellest lenses..

Read More
ZEISS Canada

ZEISS, Pioneering Excellence in Optical Innovation and Service

ZEISS, the global leader in optical science, is investing in innovation and making further advancements in the industry’s best service and quality.

Read More

Essilor Stellest Lenses Now Available in Sun Tints and an Extended Range

Essilor® Stellest™ lenses slow down myopia progression by 67% on average, compared to single vision lenses, when worn 12 hours a day.

Learn More

WCO and CooperVision Partner on Myopia Management Navigator Educational Resource

Interactive Guide Aimed at Boosting Adoption of Myopia Management Global Standard of Care

Read more
contact lens institute

New Research Report Highlights Actions to Attract Potential & Former Contact Lens Patients

Contact Lens Institute™ Data Illustrates Significant Upside Opportunity for Eye Care Practices and Pinpoints What Drives Consideration

Read more

EssilorLuxottica to Release New Research Findings at ARVO, Including Five-year Clinical Findings of Essilor Stellest Lenses

EssilorLuxottica is taking part in the 2024 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Seattle, USA, where it will present new findings from its studies on advancements in myopia management with Essilor Stellest lenses..

Read more
ZEISS Canada

ZEISS, Pioneering Excellence in Optical Innovation and Service

ZEISS, the global leader in optical science, is investing in innovation and making further advancements in the industry’s best service and quality.

Read more

Essilor Stellest Lenses Now Available in Sun Tints and an Extended Range

Essilor® Stellest™ lenses slow down myopia progression by 67% on average, compared to single vision lenses, when worn 12 hours a day.

Learn More

WCO and CooperVision Partner on Myopia Management Navigator Educational Resource

Interactive Guide Aimed at Boosting Adoption of Myopia Management Global Standard of Care

Read more
contact lens institute

New Research Report Highlights Actions to Attract Potential & Former Contact Lens Patients

Contact Lens Institute™ Data Illustrates Significant Upside Opportunity for Eye Care Practices and Pinpoints What Drives Consideration

Read more

EssilorLuxottica to Release New Research Findings at ARVO, Including Five-year Clinical Findings of Essilor Stellest Lenses

EssilorLuxottica is taking part in the 2024 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Seattle, USA, where it will present new findings from its studies on advancements in myopia management with Essilor Stellest lenses..

Read more
ZEISS Canada

ZEISS, Pioneering Excellence in Optical Innovation and Service

ZEISS, the global leader in optical science, is investing in innovation and making further advancements in the industry’s best service and quality.

Read more